AUTHOR=Zhao Wei , Li Chao , Shen Wen Zhi , Li Kai Yun , Cai Yi Xi , Li Feng , Fu Hong , Peng Bin , Chen Jie , Li Ting Yu , Chen Li TITLE=Cord blood vitamin A and vitamin D levels in relation to physical growth in exclusively breastfed infants aged 0-6 months JOURNAL=Frontiers in Endocrinology VOLUME=15 YEAR=2024 URL=https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2024.1394408 DOI=10.3389/fendo.2024.1394408 ISSN=1664-2392 ABSTRACT=Background

Vitamins A and D are essential for the health of pregnant women and infants. Nevertheless, the relationship between umbilical cord blood vitamins A and D levels and the physical growth of exclusively breastfed infants remains uncertain.

Objective

This cohort study aims to examine the relationship between cord blood vitamins A and D levels and the physical growth of exclusively breastfed infants aged 0–6 months.

Methods

140 singleton mother–infant pairs were recruited in total. Questionnaires were used to collect maternal and infant information, and liquid chromatography was utilized to quantify the levels of vitamins A and D in the umbilical cord blood. Anthropometric measurements were conducted at birth, at 3 and 6 months of age, and the weight-for-age z-score (WAZ), length-for-age z-score (LAZ), head circumference-for-age z-score (HAZ), and BMI-for-age z-score (BMIZ) were calculated. Univariate and multivariate linear regression models were used for the analysis.

Results

The average concentration of vitamins A and D in cord blood was 0.58 ± 0.20 μmol/L and 34.07 ± 13.35 nmol/L, both below the normal range for children. After adjusting for confounding factors, vitamin A levels in cord blood positively correlated with HAZ growth in infants aged 3–6 months (β= 0.75, P < 0.01) while vitamin D levels negatively correlated with LAZ growth (β= −0.01, P = 0.01) and positively correlated with BMIZ growth (β= 0.02, P < 0.01).

Conclusion

Higher Vitamin A levels at birth promote HAZ growth in infants aged 3–6 months while higher vitamin D levels at birth promote BMIZ growth in infants aged 3–6 months.

Clinical trial registration

https://register.clinicaltrials.gov, identifier NCT04017286.